Jennison Associates’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-540,612
| Closed | -$8.1M | – | 631 |
|
|
2023
Q3 | $8.1M | Buy |
540,612
+3,748
| +0.7% | +$56.2K | 0.01% | 383 |
|
|
2023
Q2 | $17.4M | Sell |
536,864
-360,092
| -40% | -$11.7M | 0.01% | 333 |
|
|
2023
Q1 | $35.1M | Buy |
896,956
+220,833
| +33% | +$8.64M | 0.03% | 241 |
|
|
2022
Q4 | $35.7M | Sell |
676,123
-9,921
| -1% | -$524K | 0.04% | 236 |
|
|
2022
Q3 | $30.9M | Buy |
686,044
+235,762
| +52% | +$10.6M | 0.03% | 250 |
|
|
2022
Q2 | $16.4M | Sell |
450,282
-234,488
| -34% | -$8.53M | 0.02% | 334 |
|
|
2022
Q1 | $28.3M | Sell |
684,770
-5,052
| -0.7% | -$209K | 0.02% | 307 |
|
|
2021
Q4 | $29.4M | Buy |
689,822
+113,974
| +20% | +$4.86M | 0.02% | 298 |
|
|
2021
Q3 | $31.7M | Buy |
575,848
+356,271
| +162% | +$19.6M | 0.02% | 291 |
|
|
2021
Q2 | $10.5M | Sell |
219,577
-144,200
| -40% | -$6.9M | 0.01% | 450 |
|
|
2021
Q1 | $18.4M | Sell |
363,777
-760,503
| -68% | -$38.5M | 0.01% | 364 |
|
|
2020
Q4 | $70.8M | Sell |
1,124,280
-130,483
| -10% | -$8.22M | 0.05% | 151 |
|
|
2020
Q3 | $84.3M | Sell |
1,254,763
-279,978
| -18% | -$18.8M | 0.07% | 111 |
|
|
2020
Q2 | $64.3M | Buy |
1,534,741
+198,912
| +15% | +$8.33M | 0.06% | 131 |
|
|
2020
Q1 | $42.1M | Buy |
1,335,829
+109,966
| +9% | +$3.46M | 0.05% | 164 |
|
|
2019
Q4 | $49.5M | Buy |
1,225,863
+181,977
| +17% | +$7.35M | 0.05% | 190 |
|
|
2019
Q3 | $34M | Buy |
1,043,886
+617,337
| +145% | +$20.1M | 0.04% | 242 |
|
|
2019
Q2 | $20.7M | Buy |
+426,549
| New | +$20.7M | 0.02% | 347 |
|